arx788
Showing 1 - 7 of 7
HER2 Mutation-Related Tumors, HER2 Amplified Solid Tumors Trial in Miami Beach, Kansas City (ARX788)
Withdrawn
- HER2 Mutation-Related Tumors
- HER2 Amplified Solid Tumors
- ARX788
-
Miami Beach, Florida
- +1 more
Apr 22, 2022
HER2-positive Breast Cancer Trial in Shenyang (ARX788, Pyrotinib maleate, Trastuzumab)
Recruiting
- HER2-positive Breast Cancer
- ARX788
- +5 more
-
Shenyang, Liaoning, ChinaShengjing Hospital affiliated to China Medical University
Jun 21, 2022
HER2 Mutation-Related Tumors, HER2 Amplification Trial (ARX788)
Not yet recruiting
- HER2 Mutation-Related Tumors
- HER2 Amplification
- ARX788
- (no location specified)
Aug 23, 2021
Breast Tumors, Gastric Tumor, Solid Tumors Trial in Australia, United States (ARX788)
Recruiting
- Breast Neoplasms
- +2 more
- ARX788
-
Los Angeles, California
- +8 more
Feb 25, 2022
HER2 Positive Metastatic Breast Cancer Trial in Worldwide (ARX788)
Active, not recruiting
- HER2 Positive Metastatic Breast Cancer
- ARX788
-
Glendale, California
- +52 more
Oct 25, 2022
Breast Tumors, Stomach Tumors Trial in Australia, New Zealand (ARX788)
Terminated
- Breast Neoplasms
- Stomach Neoplasms
- ARX788
-
South Brisbane, Queensland, Australia
- +6 more
Jun 3, 2020
Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG
Recruiting
- Breast Neoplasms
- +10 more
- Standard Therapy
- +32 more
-
Birmingham, Alabama
- +35 more
Nov 17, 2022